Metab-L

Metab-L is a rare genetic disorder that affects the body's ability to break down certain proteins. It is characterized by a deficiency in the enzyme Beta-ketothiolase, which is involved in the metabolism of amino acids and lipids. This deficiency leads to a buildup of harmful substances in the body, causing a variety of symptoms.

Symptoms[edit | edit source]

The symptoms of Metab-L can vary widely, but they often include:

Causes[edit | edit source]

Metab-L is caused by mutations in the ACAT1 gene. This gene provides instructions for making the enzyme beta-ketothiolase. When this gene is mutated, the enzyme's activity is reduced or eliminated, leading to the symptoms of Metab-L.

Diagnosis[edit | edit source]

Diagnosis of Metab-L is typically made through genetic testing, which can identify mutations in the ACAT1 gene. Other tests, such as urine tests and blood tests, may also be used to detect the buildup of harmful substances in the body.

Treatment[edit | edit source]

Treatment for Metab-L is primarily focused on managing symptoms and preventing complications. This may include dietary restrictions, medications to control seizures, and regular monitoring of metabolic and nutritional status.

Prognosis[edit | edit source]

The prognosis for individuals with Metab-L can vary widely, depending on the severity of symptoms and the individual's response to treatment. With early diagnosis and appropriate management, many individuals with Metab-L can lead healthy lives.

References[edit | edit source]

Metab-L Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.